ストックスクリーナーアプリを入手
25.38
0.34%
0.085
Catalyst Pharmaceuticals Inc (CPRX) 最新ニュース
If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now - sharewise
Catalyst Pharmaceuticals (CPRX) CEO Acquires 70,000 Shares | CPR - GuruFocus
What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Insider Sell: Richard Daly Sells 70,000 Shares of Catalyst Pharm - GuruFocus
Catalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical Officer - Yahoo Finance
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Catalyst Pharmaceuticals names new Chief Medical Officer By Investing.com - Investing.com South Africa
Catalyst Pharma Appoints New Chief Medical Officer - TipRanks
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer - GlobeNewswire
Catalyst Pharmaceuticals names new Chief Medical Officer - Investing.com
Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term - Yahoo Finance
Catalyst Pharmaceuticals (CPRX) Names New Chief Medical Officer | CPRX Stock News - GuruFocus
Catalyst Pharmaceuticals Announces Appointment of William T. And - GuruFocus
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer | CPRX Stock News - GuruFocus
Catalyst Pharmaceuticals Taps Harvard-Yale Veteran with 18 Years Rare Disease Expertise as New CMO - Stock Titan
What is Zacks Research’s Forecast for CPRX FY2025 Earnings? - Defense World
(CPRX) Trading Report - news.stocktradersdaily.com
Catalyst: Solid Business Model Propels Growth For This Buy And Build Pharma (NASDAQ:CPRX) - Seeking Alpha
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Zacks Research Brokers Raise Earnings Estimates for CPRX - Defense World
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Earnings Are Not Doing Enough For Some Investors - simplywall.st
ProShare Advisors LLC Boosts Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
D. E. Shaw & Co. Inc. Buys Shares of 18,173 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Position Decreased by Jane Street Group LLC - Defense World
Cetera Investment Advisers Grows Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Ameriprise Financial Inc. Grows Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Transcript : Catalyst Pharmaceuticals, Inc.Shareholder/Analyst Call - marketscreener.com
Catalyst Pharmaceuticals at Bank of America 2025: Strategic Expansion and Growth - Investing.com Canada
Transcript : Catalyst Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08 - marketscreener.com
The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business - Yahoo Finance
Catalyst pharmaceuticals reaffirms 2025 revenue guidance of $545M-$565M with strong FIRDAPSE and AGAMREE performance - MSN
(CPRX) Trading Signals - news.stocktradersdaily.com
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y - MSN
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2025 Earnings Call Transcript - Insider Monkey
Catalyst Pharmaceuticals Reports Record Q1 2025 Results - TipRanks
Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives $32.29 Consensus PT from Analysts - Defense World
Earnings call transcript: Catalyst Pharmaceuticals Q1 2025 earnings beat fails to impress market - Investing.com UK
Catalyst Pharmaceuticals Reports Robust Growth in Earnings Call - TipRanks
Catalyst Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Catalyst Pharmaceuticals (CPRX) Exceeds Q1 Revenue Expectations - GuruFocus
CPRX Reaffirms Positive 2025 Revenue Outlook | CPRX Stock News - GuruFocus
Catalyst Pharma Reports Record Q1 2025 Financial Results - TipRanks
Earnings Flash (CPRX) Catalyst Pharmaceuticals Reports Q1 Revenue $141.4M, vs. FactSet Est of $131.5M - marketscreener.com
Earnings Flash (CPRX) Catalyst Pharmaceuticals Reports Q1 Adjusted EPS $0.68, vs. FactSet Est of $0.48 - marketscreener.com
Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Catalyst Pharmaceuticals Inc (CPRX) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
BlackRock, Inc. Reduces Stake in Catalyst Pharmaceuticals Inc - GuruFocus
How To Trade (CPRX) - news.stocktradersdaily.com
Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Catalyst Pharmaceuticals to Participate in the BofA Securities H - GuruFocus
0.00%
0.24%
大文字化:
|
ボリューム (24 時間):